State Street Corp 4 D Molecular Therapeutics, Inc. Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

A detailed history of State Street Corp transactions in 4 D Molecular Therapeutics, Inc. stock. As of the latest transaction made, State Street Corp holds 2,116,508 shares of FDMT stock, worth $18.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,116,508

Previous 2,079,276 1.79%

Holding current value

$18.4 Million

Previous $43.6 Million 47.58%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$10.81 - $27.22 $402,477 - $1.01 Million	37,232 Added 1.79%	2,116,508 $22.9 Million
Q2 2024 Aug 14, 2024	SELL	$20.93 - $30.01 $2.07 Million - $2.97 Million	-98,954 Reduced 4.54%	2,079,276 $43.6 Million
Q1 2024 May 15, 2024	BUY	$17.03 - $35.87 $11.1 Million - $23.5 Million	654,240 Added 42.93%	2,178,230 $69.4 Million
Q4 2023 Feb 14, 2024	SELL	$9.76 - $21.25 $1.88 Million - $4.1 Million	-193,130 Reduced 11.25%	1,523,990 $30.9 Million
Q3 2023 Nov 14, 2023	SELL	$12.64 - $19.76 $4.21 Million - $6.59 Million	-333,310 Reduced 16.26%	1,717,120 $21.9 Million
Q2 2023 Aug 14, 2023	BUY	$15.16 - $23.26 $124,933 - $191,685	8,241 Added 0.4%	2,050,430 $37.1 Million
Q1 2023 May 15, 2023	BUY	$15.45 - $23.19 $12.5 Million - $18.7 Million	807,031 Added 65.34%	2,042,189 $35.1 Million
Q4 2022 Feb 14, 2023	BUY	$6.85 - $25.46 $3.82 Million - $14.2 Million	557,982 Added 82.4%	1,235,158 $27.4 Million
Q3 2022 Nov 15, 2022	BUY	$6.96 - $11.48 $310,770 - $512,593	44,651 Added 7.06%	677,176 $5.44 Million
Q2 2022 Aug 15, 2022	SELL	$5.68 - $15.99 $4.87 Million - $13.7 Million	-856,846 Reduced 57.53%	632,525 $4.42 Million
Q1 2022 May 16, 2022	BUY	$13.16 - $22.64 $3.02 Million - $5.2 Million	229,711 Added 18.24%	1,489,371 $22.5 Million
Q4 2021 Feb 14, 2022	BUY	$19.56 - $32.94 $18.4 Million - $31 Million	939,998 Added 294.06%	1,259,660 $27.6 Million
Q3 2021 Nov 15, 2021	BUY	$22.73 - $36.04 $3.5 Million - $5.56 Million	154,170 Added 93.16%	319,662 $8.62 Million
Q2 2021 Aug 16, 2021	BUY	$22.2 - $42.29 $1.3 Million - $2.48 Million	58,659 Added 54.91%	165,492 $3.99 Million
Q1 2021 May 17, 2021	BUY	$35.94 - $52.67 $3.84 Million - $5.63 Million	106,833 New	106,833 $4.63 Million

Others Institutions Holding FDMT

# of Institutions

144

Shares Held

57.7M

Call Options Held

137K

Put Options Held

111K

View Full List

About 4D Molecular Therapeutics, Inc.

Ticker FDMT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,382,400
Market Cap $281M
Description
4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical tr...

More about FDMT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp 4 D Molecular Therapeutics, Inc. Transaction History